Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate a scoring tool to help determine the presence of Heparin Induced Thrombocytopenia (HIT), which is an adverse reaction to heparin. We hypothesize that this scor...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Medstar Health Research Institute
Collaborators
NCT00861692 · Heparin-induced Thrombocytopenia Type II
NCT06066762 · Heparin-induced Thrombocytopenia
NCT05783895 · Heparin-induced Thrombocytopenia
NCT04842760 · Platelet Disorder, Heparin-induced Thrombocytopenia, and more
NCT03809481 · Heparin-induced Thrombocytopenia
Washington Hospital Center
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions